PACLITAXEL-GA paclitaxel 150mg/25mL solution for injection vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

paclitaxel, Quantity: 6 mg/mL

Доступна с:

Medis Pharma Pty Ltd

ИНН (Международная Имя):

Paclitaxel

Фармацевтическая форма:

Injection, solution

состав:

Excipient Ingredients: ethanol absolute; PEG-35 castor oil

Администрация маршрут:

Intravenous

Штук в упаковке:

1 x 25mL vial

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

Paclitaxel-GA is indicated for: * Primary treatment of ovarian cancer in combination with a platinum agent; Treatment of metastatic carcinoma of the ovary and of the breast after failure of standard therapy; Adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide; Treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin), in patients who have tumours that over-express HER-2 and who have not received previous chemotherapy for their metatastic disease; Treatment of non-small cell lung cancer (NSCLC); In combination with gemcitabine (Gemzar), is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/ neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated.

Обзор продуктов:

Visual Identification: Clear colourless to yellow viscous solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Статус Авторизация:

Registered

Дата Авторизация:

2008-08-18